RHB-104
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RHB-104, covering 2016-07-28 to 2016-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 2]